Senseonics Holdings, Inc. (SENS) Dividend History

Senseonics Holdings, Inc. (SENS) is a medical technology company that develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes. Known for its implantable Eversense CGM system, the company aims to improve diabetes management through innovative, long-term sensor solutions that provide real-time glucose data.

Dividend History

Senseonics Holdings, Inc. currently does not pay dividends

Company News

  • Senseonics Holdings, Inc. announced the closing of a public offering of 115 million shares of its common stock, raising $57.5 million in gross proceeds. The company also closed a private placement with Abbott Laboratories, who acquired 40.5 million shares for $20.3 million. The proceeds will be used to fund the launch of Eversense 365 and development of pipeline products.

    GlobeNewswire Inc.
    Featured Companies: ABT
  • Senseonics Holdings (SENS) collaborates with Mercy to bring its Eversense CGM to a healthcare system that is likely to drive its adoption.

    Zacks Investment Research
    Featured Companies: ALGN DVA MEDP
  • Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results. Zscaler posted better-than-expected earnings and sales results for its second quarter on Thursday. The company said it expects fiscal year 2024 non-GAAP income from operations between $395 million and $400 million and net income per share between $2.73 and $2.77. Zscaler shares fell 10.1% to $217.43 on Friday. Here are some other stocks moving in today's mid-day session. Gainers BioVie Inc. (NASDAQ: BIVI) shares climbed 96.1% to $2.4319. BioVie's Ne3107 demonstrated potential improvements in motor and non-motor symptoms for Parkinson's disease patients and may be realigning physiological processes for Alzheimer's patients. Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) gained 68.4% to $3.4350. Adial Pharmaceuticals was awarded a new patent covering AD04 for the potential treatment of opioid use disorder. Cardiff Oncology, Inc. (NASDAQ: CRDF) shares rose 41.5% to $2.50 after the company reported better-than-expected fourth-quarter financial results, provided a clinical update on the Phase 2 randomized second-line ONSEMBLE trial in patients with RAS-mutated mCRC and announced the first patient was dosed in the randomized first-line RAS-mutated mCRC trial. Minim, Inc. (NASDAQ: MINM) shares rose 41.4% to $6.09. On Feb. 20, Minim entered into an employment agreement with David Lazar to engage him as CEO, CFO, following resignation of Jeremy Hitchcock. The RealReal, Inc. (NASDAQ: REAL) gained 39.1% to $2.4613 following upbeat quarterly results. Nxu, Inc. (NASDAQ: NXU) shares gained 36.4% to $1.09 after the company announced it successfully charged a Tesla Cybertruck on Feb. 26. Jaguar Health, Inc. (NASDAQ: JAGX) climbed 35.3% to $0.0798. Dell Technologies Inc. (NYSE: DELL) rose 26.3% to $119.52 as the company reported better-than-expected fourth-quarter financial results and increased its annual cash dividend by 20%. Sweetgreen, Inc. (NYSE: SG) gained 26% to $16.05 after the company reported better-than-expected fourth-quarter financial results. MMTec, Inc. (NASDAQ: MTC) climbed 25% to $1.61. Everbridge, Inc. (NASDAQ: EVBG) rose 24.5% to $35.19 after it amended and restated the previously announced merger agreement with Thoma Bravo. NetApp, Inc. (NASDAQ: NTAP) shares gained 24.4% to $110.85 after the company reported better-than-expected third-quarter financial results ...

    Benzinga
  • Best penny stocks to buy right now? Here are 4 to watch in the stock market today. The post Top Penny Stocks To Buy Now? 4 To Watch Under $4 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: SOUN STEM
  • These two low-priced biotech stocks could produce life-changing returns for early shareholders.

    The Motley Fool
    Featured Companies: ABT AXSM BMY DXCM EXEL MRK TSLA
Page data last updated 07/23/2025 03:25:25 UTC